The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Chicherina E.N.

Kafedra vnutrennikh bolezneĭ Kirovskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Padyganova A.V.

Kafedra vnutrennikh bolezneĭ Kirovskoĭ gosudarstvennoĭ meditsinskoĭ akademii;
Kirovskiĭ oblastnoĭ klinicheskiĭ perinatal'nyĭ tsentr

Factors for the development and progression of cardiorenal complications in women

Authors:

Chicherina E.N., Padyganova A.V.

More about the authors

Journal: Therapeutic Archive. 2013;85(6): 85‑89

Read: 451 times

Download PDF (RU)
Contact the author
Table of contents

FACTORS FOR THE DEVELOPMENT AND PROGRESSION OF CARDIORENAL COMPLICATIONS IN WOMEN
FACTORS FOR THE DEVELOPMENT AND PROGRESSION OF CARDIORENAL COMPLICATIONS IN WOMEN

To cite this article:

Chicherina EN, Padyganova AV. Factors for the development and progression of cardiorenal complications in women. Therapeutic Archive. 2013;85(6):85‑89. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Comparison of models for prediction of spontaneous preterm birth. Medi­cal Technologies. Asse­ssment and Choice. 2024;(4):10-19
Stru­ctural and functional features of the main arte­ries of the brain and tumor necrosis factor-alpha in people with chro­nic non-infectious diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):178-184
Gastric cancer: inci­dence, risk factors, screening. Russian Journal of Preventive Medi­cine. 2024;(12):135-139
Features of primary and recu­rrent ischemic stroke in men aged 18—50 years. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):65-74
Treatment of children with blunt spleen injury throughout 25-year period in Seva­stopol and the Repu­blic of Crimea. Piro­gov Russian Journal of Surgery. 2025;(2):67-76
A case of Becker muscular dystrophy in a woman with skewed X-chromosome inactivation. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):139-144
Clinical and anamnestic features of rosa­cea in women in peri­menopausal period. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):49-55
Risk factors and adve­rse outcomes of cardiovascular diseases in people with high normal blood pressure of the Ryazan region. (5-year prospective follow-up). Russian Journal of Preventive Medi­cine. 2025;(2):31-37
The Rela­tionship of obstructive sleep apnea with paro­xysmal atrial fibrillation in women suffered coro­nary heart disease and arte­rial hype­rtension. Russian Journal of Preventive Medi­cine. 2025;(2):61-66
Asso­ciations of subclinical athe­rosclerosis with soma­tic diseases. Russian Journal of Preventive Medi­cine. 2025;(2):109-113
Abstract:

The paper describes the state-of-the-art of risk factors for cardiorenal complications in women. It is shown that while managing women of reproductive, menopausal, and menopausal ages, great importance should be attached to the assessment of all risk factors for the development and progression of chronic renal and cardiovascular diseases. Investigations of the specific features of these factors in women, their enrollment along with men in large-scale randomized trials will serve as a basis for developing more effective programs for the prevention and therapy for cardiovascular and renal diseases and hence will be able to reduce disability rates, to increase quality of life, and to prolong its span.

Keywords:

cardiorenal complications
risk factors
women

Authors:

Chicherina E.N.

Kafedra vnutrennikh bolezneĭ Kirovskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Padyganova A.V.

Kafedra vnutrennikh bolezneĭ Kirovskoĭ gosudarstvennoĭ meditsinskoĭ akademii;
Kirovskiĭ oblastnoĭ klinicheskiĭ perinatal'nyĭ tsentr

Close metadata

References:

  1. Vizir V.A., Berezin A.E. Kardiorenal'nyi sindrom. Arterial'naya gipertenziya 2011; 2 (16): http://hypertension.mif-ua.com/archive/issue-17133/article-17155/
  2. Ninomiya T., Kiyohara Y., Kubo M. et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: The Hisayama Study. Kidney Int 2005; 68: 228-236.
  3. Clase C.M., Garg A.X., Kiberd B.A. Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 2002; 13 (5): 1338-1349.
  4. Coresh J., Astor B.C., Greene T. et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41 (1): 1-12.
  5. Sarnak M.J., Levey A.S., Schoolwerth A.C. et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42: 1050-1065.
  6. Renal Inssuficiency as a predictor of cardiovascular outcomes and the impact of Ramipril: The HOPE Randomized Trial. Ann Intern Med 2001; 143: 629-636.
  7. Moiseev C.B., Kobalava Zh.D. Kardiorenal'nyi sindrom (pochechnyi faktor i povyshenie riska serdechno-sosudistykh zabolevanii. Klin farmakol i ter 2002; 3: 16-18.
  8. Mukhin N.A., Moiseev V.S, Kobalava Zh.D. i dr. Kardiorenal'nye vzaimodeistviya: klinicheskoe znachenie i rol' v patogeneze zabolevanii serdechno-sosudistoi sistemy i pochek. Ter arkh 2004; 6: 39-46.
  9. Klinicheskie rekomendatsii "Funktsional'noe sostoyanie pochek i prognozirovanie serdechno-sosudistogo riska". Vserossiiskoe nauchnoe obshchestvo kardiologov. M 2009; 20.
  10. Smirnov A.V., Dobronravov V.A., Kayukov I.G. Kardiorenal'nyi kontinuum: patogeneticheskie osnovy preventivnoi nefrologii. Nefrologiya 2005; 3: 7-15.
  11. Natsional'nye rekomendatsii po kardiovaskulyarnoi profilaktike. Kardiovask ter i prof 2011; 6 (prilozhenie 2): http://www.scardio.ru/journals/item00282/default.asp
  12. Prokhorovich E.A., Vladimirova N.N., Kul'nichenko T.V. Profilaktika serdechno-sosudistykh zabolevanii u zhenshchin. Rus med zhurn 2007; 5: http://www.rmj.ru/articles_4454.htm
  13. Stangl V., Baumann G., Stangl K. Coronary aterogenetic risk factors in women. Eur Heard J 2002; 23: 1738-1752.
  14. Rekomendatsii po snizheniyu obshchego riska razvitiya zabolevanii i oslozhnenii u zhenshchin. Po red. M.G. Glezer, O.N. Tkachevoi. M 2010; 48.
  15. Shal'nova S.A., Deev A.D., Karpov Yu.A. Arterial'naya gipertoniya i ishemicheskaya bolezn' serdtsa v real'noi praktike vracha-kardiologa. Kardiovask ter i prof 2006; 2: 73-80.
  16. Shal'nova S.A., Deev A.D., Oganov R.G. Faktory, vliyayushchie na smertnost' ot serdechno-sosudistykh zabolevanii v rossiiskoi populyatsii. Kardiovask ter i prof 2005; 1: 4-8.
  17. Deo R., Lin F., Shlipak M. Kidney Dysfunction and Sudden Cardiac Death Among Women With Coronary Heart Disease. Hypertension 2008; 51: 1578-1582.
  18. Jacobs A.K., Kelsey S.F., Brooks M.M. et al. Better outcome for women compared with men undergoing coronary revascularization: a report from the bypass angioplasty revascularization investigation (BARI). Circulation 1998; 98 (13): 1279-1285.
  19. Duvernoy C.S., Smith D.E., Manohar P. et al. Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: An analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registry. Am Heart J 2010; 159: 677-683.
  20. Geddes K.G., Maktier R. Kak otsenit' pochechnuyu funktsiyu v klinicheskoi praktike? Rus med zhurn 2008; 20: 1354-1357.
  21. National Kidney Foundation. Kidney Disease Outcome Quality Initiative (KDOQI). Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007; 49: 170-180.
  22. National Chronic Kidney Disease Fact Sheet: general information and national estimates on chronic kidney disease in the United States, 2010. Atlanta, GA. http://www.cdc.gov/diabetes/pubs/factsheets/kidney.htm
  23. Sigitova O.N. Khronicheskaya bolezn' pochek: prichiny, rasprostranennost', meditsinskie i sotsial'no-ekonomicheskie posledstviya. Med farm vestn Povolzh'ya 2011; 15: http://mfvt.ru/xronicheskaya-bolezn-pochek-prichiny-rasprostranennost-medicinskie-i-socialno-ekonomicheskie-posledstviya/
  24. Go A.S., Chertow G.M., Fan D. et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351 (13): 1296-305.
  25. Moiseev V.S., Kobalava Zh.D. Kardiorenal'nye sindromy (patogeneticheskie, kliniko-diagnosticheskie, prognosticheskie i terapevticheskie aspekty). Ter arkh 2011; 12: 5-11.
  26. Dislipidemii i ateroskleroz. Biomarkery, diagnostika i lechenie: rukovodstvo dlya vrachei. Pod red. R.G. Oganova. M: GEOTAR-Media. 2009; 160.
  27. Natsional'nye rekomendatsii po diagnostike i korrektsii narushenii lipidnogo obmena s tsel'yu profilaktiki i lecheniya ateroskleroza. Kardiovask ter i prof 2007; 6 (6). Prilozhenie 3: http://www.scardio.ru/journals/item00282/default.asp
  28. Klinicheskie rekomendatsii "Diagnostika i lechenie arterial'noi gipertenzii u beremennykh". Vserossiiskoe nauchnoe obshchestvo kardiologov. M 2010; 84.
  29. Saigitov R.T., Glezer M.G., Sementsov D.P. Prognozirovanie postgospital'noi letal'nosti u muzhchin i zhenshchin, nablyudavshikhsya po povodu ostrogo koronarnogo sindroma. Ros kardiol zhurn 2006; 3: 41-48.
  30. USRDS: U.S. Renal Data System. USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda. 2002.
  31. Diabetes Prevention Program Research Group. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. N Engl J Med 2002; 346: 393-403.
  32. Elevated Triglycerides Make a Difference in Women's Risk of CHD. Am Fam Physician 2006; 73 (11): 1907.
  33. Ivanov D.D. Vybor farmakoterapii pri khronicheskoi bolezni pochek u zhenshchin. Zdorov'e Ukrainy 2008; 3 (12): http://woman.health-ua.com/article/162.html
  34. Almazov V.A., Blagosklonnaya Ya.V., Shlyakhto E.V. i dr. Metabolicheskii serdechno-sosudistyi sindrom. SPb: SPb GMU 1999; 203.
  35. Grigoryan O.R., Andreeva E.N., Dedov I.I. Menopauzal'nyi sindrom u zhenshchin s narusheniyami uglevodnogo obmena. Trudnyi patsient 2007; 9: http://www.t-pacient.ru/archive/tp9-2007/tp9-2007_343.html
  36. Lovejoy J.C. The influence of sex hormones on obesity across the female life span. J Women Health 1998; 7: 1247-1256.
  37. Dedov I.I., Mel'nichenko G.A. Ozhirenie: etiologiya, patogenez, klinicheskie aspekty. M: MIA 2004.
  38. Krapivina N.A., Artymuk N.V., Tachkova O.A. Optimizatsiya terapii ozhireniya u zhenshchin reproduktivnogo vozrasta. Consilium Medicum Ginekologiya 2006; 8 (4): http://www.consilium-medicum.com/article/7830
  39. Milewicz A., Bidzinska B., Sidorowicz A. Perimenopausal obesity. Gynecol Endocrinol 1996; 10: 285-291.
  40. Ginzburg M.M., Kryukov N.N. Ozhirenie. Vliyanie na razvitie metabolicheskogo sindroma. Profilaktika i lechenie. M: Medpraktika 2002.
  41. Hsu C., McCulloch C.E., Iribarren C. et al. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 21-28.
  42. Kalantar-Zadeh K., Koppel J.D., Kilpatrick R.D. et al. Association of morbid obesity and weight change over time with cardiovascular survival with hemodialysis population. Am J Kidney Dis 2005; 46: 489-500.
  43. Khronicheskaya bolezn' pochek: osnovnye polozheniya, opredelenie, diagnostika, skrining, podkhody k profilaktike i lecheniyu. Natsional'nye rekomendatsii (proekt) 2011. http://journal.nephrolog.ru/ckd/
  44. Mukhin N.A. Khronicheskaya bolezn' pochek u zhenshchin. Klin farmakol i ter 2011; 4: 70-75.
  45. Ushkalova E.A. Rol' gipergomotsisteinemii i defitsita vitaminov gruppy B v razvitii oslozhnenii beremennosti. Farmateka 2007; 14: 10-15.
  46. Rouse D.J. Potential Cost-Effectiveness of Nutrition Interventions of Prevent Adverse Pregnancy Outcomes in the Developing World. J Nutr 2003; 133 (5): 1640-1644.
  47. Welch G., Loscalo J. Homocysteine and atherosclerosis. New Engl J Med 1998; 338 (15): 1042-1050.
  48. Mukhin N.A., Moiseev V.S, Kobalava Zh.D. i dr. Kardiorenal'nye vzaimodeistviya: klinicheskoe znachenie i rol' v patogeneze zabolevanii serdechno-sosudistoi sistemy i pochek. Ter arkh 2004; 6: 39-46.
  49. Pontremoli R., Nicolella C., Viazzi F. et al. Microalbuminuria is an early marker of target organ damage in essential hypertension. Am J Hypertens 1998; 11 (4): 430-438.
  50. World Health Organization. Iron deficiency anemia: Assessment, prevention and control. Geneva: WHO 2001: 114.
  51. Guseva S.A., Voznyuk V.P. Bolezni sistemy krovi. M: Meditsina 2004.
  52. Goncharova E.V. Anemicheskoe serdtse: zakonomernosti razvitiya, diagnostika, patogeneticheskoe obosnovanie terapii: Avtoref. dis. ... d-ra med. nauk. Irkutsk 2009; 38.
  53. Arutyunov G.P. Anemii u bol'nykh khronicheskoi serdechnoi nedostatochnost'yu. Serdech nedostat 2003; 5: 224-228.
  54. Belyalov F.I. Diagnostika i lechenie ishemicheskoi bolezni serdtsa pri khronicheskoi pochechnoi nedostatochnosti. Klin med 2004; 10: 8-12.
  55. Donne R.L. Anemia management and cardiomyopathy in renal failure. Nephrol Dial Transplant 2002; 17 (11): 37-40.
  56. Petrova E.V. Patogeneticheskie osobennosti anemii, oslozhnyayushchei beremennost'. Meditsina 2007; 1: 23-24.
  57. Smirnov A.V., Volkov M.M., Dobronravov V.A. i dr. Fosforno-kal'tsievyi obmen i sostoyanie serdechno-sosudistoi sistemy u patsientov s rannimi stadiyami khronicheskoi bolezni pochek. Ter arkh 2010; 6: www.medlit.ru/medrus/ta/ta/100625.htm
  58. Mikhailov E.E., Benevolenskaya L.I. Epidemiologiya osteoporoza i perelomov. Rukovodstvo po osteoporozu. Pod red. L.I. Benevolenskoi. M: Binom 2003; 10-53.
  59. Lazebnik L.B., Malichenko S.B. Pervichnyi osteoporoz: klinika, diagnostika i lechenie. Lech vrach 1999; 7 www.lvrach.ru/1999/07/4527954
  60. Kremer H., Toto R., Peshock R. et al. Association between Chronic Kidney Disease and Coronary Artery Calcification: The Dallas Heart Study. J Am Soc Nephrol 2005; 16: 507-513.
  61. Naumov A.V., Vertkin A.L., Skotnikov A.S. i dr. Osteoporoz - komponent serdechno-sosudistogo kontinuuma. Lech vrach 2012; 2: http://www.lvrach.ru/2012/02/15435341
  62. Nowak Z., Tlustochowicz W., Wankowicz Z. Bone mineral density in patients with irreversible renal failure treated with peritoneal dialysis. Pol Arch Med Wewn 2001; 106 (5): 1035-1040.
  63. Jong P.E., Brenner B.M. From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria. Kidney Intern 2004; 66: 2109-2118.
  64. Baranova E.I., Bol'shakova O.O. Klinicheskoe znachenie gomotsisteinemii (obzor literatury). Consilium Medicum 2004; 1 (10) http://old.consilium-medicum.com/media/gyper/ 04_01/12.stml
  65. Maslova N.P., Baranova E.I. Gipertonicheskaya bolezn' u zhenshchin. SPb 2000.
  66. Irgens H.U., Reisaeter L., Irgens H.U. et al. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. Br Med J 2001; 323: 1213-1217.
  67. Yakusevich V.V., Mozheiko M.E., Sudareva N.V. i dr. Medikamentoznaya korrektsiya narushenii tserebral'nogo krovotoka u zhenshchin s arterial'noi gipertoniei v postmenopauze. Ratsion farmakoter v kardiol 2005; 3: 4-10.
  68. Bystrova M.M., Britov A.N., Gorbunov V.M. i dr. ZGT u zhenshchin s arterial'noi gipertoniei v peri- i postmenopauze: gemodinamicheskie effekty. Ter arkh 2001; 10: 33-38.
  69. Leonova M.V., Demidova M.A., Tarasov A.V. i dr. Sravnitel'naya effektivnost' i bezopasnost' sovremennykh ingibitorov angiotenzinprevrashchayushchego fermenta moeksiprila i spiraprila u zhenshchin s postmenopauzal'nym metabolicheskim sindromom. Kardiologiya 2006; 1: 43-49.
  70. Weiner D.E., Tighiouart H., Amin M.G. Cardiovascular risk in patients with mild renal insufficiency. J Am Soc Nephrol 2004; 15: 1307-1315.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.